Published in Appl Environ Microbiol on July 01, 1993
Laboratory diagnostics of botulism. Clin Microbiol Rev (2006) 2.32
Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci (2012) 1.21
Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom. J Clin Microbiol (2005) 1.18
Distribution of Clostridium botulinum type E strains in Nunavik, Northern Quebec, Canada. Appl Environ Microbiol (2012) 0.86
Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System. Appl Environ Microbiol (2014) 0.86
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain. mSphere (2016) 0.79
Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter. Biomed Res Int (2015) 0.78
Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol (1966) 3.91
Selective medium for isolation of Clostridium botulinum from human feces. J Clin Microbiol (1981) 2.16
Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin. Infect Immun (1988) 1.74
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A. Jpn J Med Sci Biol (1978) 1.49
Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem (1982) 1.34
Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures. Infect Immun (1976) 1.34
Simplified purification method for Clostridium botulinum type E toxin. Appl Environ Microbiol (1987) 1.14
Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes? J Protein Chem (1991) 1.11
Cardiac muscle. A comparative study of Purkinje fibers and ventricular fibers. J Cell Biol (1968) 5.34
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75
Heart: excitation and contraction. Annu Rev Physiol (1971) 4.24
Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc Natl Acad Sci U S A (1980) 3.58
Development of an improved chemically defined minimal medium for Listeria monocytogenes. Appl Environ Microbiol (1991) 3.06
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06
Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature (1995) 2.91
Clostridium botulinum neurotoxin. Microbiol Rev (1980) 2.89
Rabbit ileal loop response to strains of Clostridium perfringens. J Bacteriol (1968) 2.80
A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun (1972) 2.78
A strand of cardiac muscle. Its ultrastructure and the electrophysiological implications of its geometry. J Cell Biol (1967) 2.69
Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev (1992) 2.60
Mapping with RAD (restriction-site associated DNA) markers to rapidly identify QTL for stem rust resistance in Lolium perenne. Theor Appl Genet (2011) 2.41
A P element containing suppressor of hairy-wing binding regions has novel properties for mutagenesis in Drosophila melanogaster. Genetics (1995) 2.38
Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods. Appl Environ Microbiol (1995) 2.29
The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ Res (1981) 2.27
Cardiac muscle. A comparative ultrastructural study with special reference to frog and chicken hearts. Z Zellforsch Mikrosk Anat (1969) 2.15
A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature (1987) 2.15
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood (1994) 2.03
Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration. Thromb Res (1976) 2.03
Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology (1978) 1.92
Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem (1997) 1.91
Electronic structure calculations with GPAW: a real-space implementation of the projector augmented-wave method. J Phys Condens Matter (2010) 1.91
Possible origin of the high incidence of Clostridium botulinum type E in an inland bay (Green Bay of Lake Michigan). J Bacteriol (1968) 1.86
Disulfide-toxicity relationship of botulinal toxin types A, E, and F. Proc Soc Exp Biol Med (1973) 1.82
Isolation of Phaffia rhodozyma Mutants with Increased Astaxanthin Content. Appl Environ Microbiol (1989) 1.81
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80
Education, cognitive function, and severity of neuropathology in Alzheimer disease. Neurology (2007) 1.79
The initial inward current in spherical clusters of chick embryonic heart cells. J Gen Physiol (1980) 1.76
Acid adaptation induces cross-protection against environmental stresses in Salmonella typhimurium. Appl Environ Microbiol (1993) 1.76
Fast sodium current in cardiac muscle. A quantitative description. Biophys J (1980) 1.74
brp and blh are required for synthesis of the retinal cofactor of bacteriorhodopsin in Halobacterium salinarum. J Biol Chem (2000) 1.74
Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood (1997) 1.72
Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J Biol Chem (1998) 1.71
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J Biol Chem (1994) 1.67
Foliage influences forced convection heat transfer in conifer branches and buds. New Phytol (2006) 1.67
A factor from neurons increases the number of acetylcholine receptor aggregates on cultured muscle cells. Proc Natl Acad Sci U S A (1978) 1.66
Voltage clamp of cardiac muscle. A theoretical analysis of early currents in the single sucrose gap. Biophys J (1972) 1.64
Climate and wildfires in the North American boreal forest. Philos Trans R Soc Lond B Biol Sci (2008) 1.62
Paragonimus heterotremus infection in Nagaland: A new focus of Paragonimiasis in India. Indian J Med Microbiol (2009) 1.62
Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol (2001) 1.61
Dose standardisation of botulinum toxin. Lancet (1990) 1.61
Diseases associated with ulcerative colitis and Crohn's disease. Gut (1968) 1.57
Computer-assisted bacterial identification utilizing antimicrobial susceptibility profiles generated by autobac 1. J Clin Microbiol (1976) 1.56
Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res (1985) 1.53
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product. Immunogenetics (2000) 1.51
Acid adaptation promotes survival of Salmonella spp. in cheese. Appl Environ Microbiol (1992) 1.49
Characterization of mouse parvovirus infection by in situ hybridization. J Virol (1995) 1.49
Purification of Clostridium botulinum type A neurotoxin. Methods Mol Biol (2000) 1.47
Autotrophic carbon dioxide fixation in Acidianus brierleyi. Arch Microbiol (1996) 1.46
Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2001) 1.46
Microbial ecological basis of infant botulism as studied with germfree mice. Infect Immun (1979) 1.44
Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42
Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types. Am J Gastroenterol (1997) 1.42
Impaired immune response to voluntary arm-crank ergometer exercise in patients with cervical spinal cord injury. Spinal Cord (2010) 1.41
Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest (1991) 1.41
Reiter's syndrome associated with HLA-B51. Intern Med (2000) 1.41
Purification and properties of Clostridium botulinum type F toxin. Appl Microbiol (1975) 1.41
Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits. Crit Care Med (1994) 1.41
Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J Gastroenterol Hepatol (1998) 1.41
In vivo studies with an "orphan" parvovirus of mice. Lab Anim Sci (1993) 1.40
State transitions by molecules. Biosystems (1999) 1.40
Purification and properties of dihydroxyacetone kinase from Klebsiella pneumoniae. J Bacteriol (1984) 1.38
Immunological characterisation of the cholinergic receptor protein from Electrophorus electricus. FEBS Lett (1973) 1.38
Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A (1991) 1.36
Antithrombin III and heparin. Br Med Bull (1978) 1.36
Improved procedure for crystallization of Clostridium botulinum type A toxic complexes. Appl Environ Microbiol (1977) 1.35
Transmissible ileal hyperplasia of hamsters. II. Ultrastructure. Am J Pathol (1978) 1.34
Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis. Appl Environ Microbiol (1995) 1.34
The D-JH complex is an intermediate to the complete immunoglobulin heavy-chain V-region gene. Nucleic Acids Res (1983) 1.34
Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures. Infect Immun (1976) 1.34
Isolation and characterization of a protease from Clostridium botulinum type B. Biochim Biophys Acta (1972) 1.34
Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin. Appl Microbiol (1974) 1.32
Studies on the electrogenic action of acetylcholine with Torpedo marmorata electric organ. III. Pharmocological desensitization in vitro of the receptor-rich membrane fragments by cholinergic agonists. J Mol Biol (1976) 1.32
Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J Biol Chem (1997) 1.32
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes (2000) 1.31
Functional V region formation during in vitro culture of a murine immature B precursor cell line. Nature (1983) 1.30
Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood (1996) 1.29
The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis. Leukemia (2007) 1.28
Cardiac muscle. Its ultrastructure in the finch and hummingbird with special reference to the sarcoplasmic reticulum. J Cell Biol (1971) 1.26
Abdominal viscera as site of emetic action for staphylococcal enterotoxin in the monkey. J Infect Dis (1965) 1.26
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res (1999) 1.26
Electrical and biochemical properties of an enzyme model of the sodium pump. J Membr Biol (1983) 1.25
Klebsiella pneumoniae 1,3-propanediol:NAD+ oxidoreductase. J Bacteriol (1987) 1.25
Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice. Infect Immun (1982) 1.24
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol (1990) 1.24
Reconstruction of orbital wall defects: critical review of 72 patients. Int J Oral Maxillofac Surg (2007) 1.24
Chromosomal differentiation of the Schistosoma japonicum complex. Int J Parasitol (2000) 1.24
Analysis of products formed during bleomycin-mediated DNA degradation. Biochemistry (1985) 1.22
Inositol phosphate formation and chloride current responses induced by acetylcholine and serotonin through GTP-binding proteins in Xenopus oocyte after injection of rat brain messenger RNA. Brain Res (1987) 1.22
Muscarinic acetylcholine receptors of the developing retina. Proc Natl Acad Sci U S A (1977) 1.21
Low conduction in cardiac muscle. Biophysical model. Biophys J (1973) 1.21
Identification of the human beta-actin enhancer and its binding factor. Mol Cell Biol (1988) 1.21
Soybean lipoxygenase inhibition by nonsteroidal antiinflammatory drugs. Prostaglandins (1983) 1.21
Moving beyond the cambium necrosis hypothesis of post-fire tree mortality: cavitation and deformation of xylem in forest fires. New Phytol (2012) 1.20
Enhancement of neurogenesis by running wheel exercises is suppressed in mice lacking NMDA receptor epsilon 1 subunit. Neurosci Res (2003) 1.20
3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors. Neuroreport (1992) 1.20
Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect Immun (1999) 1.20
Singlet oxygen and peroxyl radicals regulate carotenoid biosynthesis in Phaffia rhodozyma. J Biol Chem (1995) 1.20